Related Experiment Video

Updated: May 22, 2025

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.2K

Exosomal RNAs and EZH2: unraveling the molecular dialogue driving tumor progression

Ahmed Hussein Zwamel1,2,3, Abdulrahman T Ahmad4, Farag M A Altalbawy5

  • 1Medical Laboratory Technique College, The Islamic University, Najaf, Iraq.

Medical Oncology (Northwood, London, England)
|March 13, 2025
PubMed

Insights

The EZH2 gene regulates gene expression and chromatin structure. Exosomal RNAs may influence EZH2 expression, impacting cancer development and progression.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Cancer Biology

Background:

  • The EZH2 gene encodes a key enzyme in Polycomb Repressive Complex 2 (PRC2), which modifies chromatin structure to control gene expression.
  • EZH2's role in histone methylation suppresses RNA transcription, and its dysregulation is linked to abnormal gene expression patterns in cancer.
  • Non-coding RNAs epigenetically regulate EZH2 expression, and exosomes, released by cells, carry various RNA molecules that can influence recipient cell gene expression.

Purpose of the Study:

  • This review focuses on the biological role of EZH2 and its regulatory mechanisms.
  • The study aims to understand the potential impact of exosomal RNAs on EZH2 expression.

Main Methods:

  • Literature review of EZH2 function, regulation, and exosomal RNA interactions.
  • Analysis of epigenetic mechanisms involving non-coding RNAs and EZH2.
  • Examination of exosome-mediated intercellular communication.

Main Results:

  • EZH2 is a critical epigenetic regulator involved in chromatin modification and gene silencing.
  • Non-coding RNAs and exosomal RNAs represent significant regulatory factors for EZH2 expression.
  • Exosomes act as intercellular messengers, transferring RNAs that can modulate EZH2 levels and downstream effects.

Conclusions:

  • EZH2 plays a crucial role in gene regulation and is implicated in cancer progression.
  • Exosomal RNAs are emerging as key players in regulating EZH2 expression through epigenetic pathways.
  • Understanding exosome-mediated EZH2 regulation offers potential insights into cancer biology and therapeutic strategies.
Keywords:
EZH2ExosomesNeoplasmRNA

More Related Videos

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.7K
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.7K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K